Greater Awareness Needed for Potential of T2DM Remission

Share this content:
Greater Awareness Needed for Potential of T2DM Remission
Greater Awareness Needed for Potential of T2DM Remission

THURSDAY, Sept. 14, 2017 (HealthDay News) -- For many patients with type 2 diabetes, remission can be achieved with sustained weight loss of ~15 kg, yet this often flies under the radar for patients and clinicians alike, according to an analysis published online Sept. 13 in The BMJ.

Noting that type 2 diabetes affects 5 to 10 percent of the U.K. population, and is associated with greater medical costs, Louise McCombie, R.D., from the University of Glasgow in the United Kingdom, and colleagues discuss the importance of achieving remission of type 2 diabetes.

The researchers note that the primary aim of management is lowering blood glucose or glycated hemoglobin (HbA1c) concentrations. Weight loss is associated with extended life expectancy, and weight loss of about 15 kg can induce total biochemical remission. There is currently no consensus on the criteria for diabetes remission; measurement of either HbA1c or blood glucose is sufficient to determine remission. Two test results (usually HbA1c) below the diagnostic threshold, at least two months apart, can confirm remission. Patients in remission should be monitored regularly with annual testing. Although no study has reported outcomes for those who achieve remission, good glycemic control is associated with improved microvascular outcomes. Patients are rarely recorded as being in remission, possibly because few patients are attempting or achieving remission.

"It is in everybody's interest to reclassify people with type 2 diabetes when they become non-diabetic," the authors write. "Official guidelines and international consensus for recording diabetes in remission are needed."

Two authors provide consultancy to Counterweight.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Extended-Release Naltrexone Promising for Opioid Dependence

Extended-Release Naltrexone Promising for Opioid Dependence

Lower use of heroin, other illicit opioids with extended-release naltrexone in superiority analysis

New Expert Consensus Pathway for Mitral Regurgitation

New Expert Consensus Pathway for Mitral Regurgitation

Etiology, mechanism, severity, indications for treatment should be assessed after MR is identified

Many Dermatology Guideline Authors Get Industry Payments

Many Dermatology Guideline Authors Get Industry Payments

22 of 40 guideline authors receiving payments did not accurately disclose industry relationships

is free, fast, and customized just for you!

Already a member?

Sign In Now »